Recognition of a novel naturally processed, A2 restricted, HCV-NS4 epitope triggers IFN-gamma release in absence of detectable cytopathicity

Human Immunology

Volumn 59, Issue 12, 1998, Pages 776-782

  Alexander, Jeff ^a   Del Guercio, Marie France ^a   Fikes, John D ^a   Chesnut, Robert W ^a   Chisari, Francis V ^b   Chang, Kyong Mi ^b   Appella, Ettore ^c   Sette, Alessandro ^a  

^a Epimmune   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; LYMPHOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; CYTOPATHOGENIC EFFECT; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, VIRAL; B-LYMPHOCYTES; CELL LINE; CHROMIUM; EPITOPES, T-LYMPHOCYTE; HEPACIVIRUS; INTERFERON TYPE II; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0032402264     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00080-9     Document Type: Article

References (28)

1. Vitiello A., Ishioka G., Grey H.M., Rose R., Farness P., LaFond R., Yuan L., Chisari F.V., Furze J., Bartholomeuz R. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. J Clin Invest. 95:1995;34.
2. Bertoni R., Sidney J., Fowler P., Chesnut R.W., Chisari F.V., Sette A. HLA-binding supermotifs predict broadly crossreactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest. 100:1997;503.
3. Livingston B.D., Crimi C., Grey H., Ishioka G., Chisari F.V., Fikes J., Grey H., Chesnut R.W., Sette A. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J Immunol. 159:1997;1383.
4. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 13:1995;29.
5. Rehermann B., Lau D., Hoofnagle J.H., Chisari F.V. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest. 97:1996;1655.
6. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Shreiber R., Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 4:1996;25.
7. Guidotti L.G., Borrow P., Hobbs M.V., Matzke B., Gesser I., Oldstone M.B., Chisari F.V. Viral cross talk intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver . Proc Natl Acad Sci USA. 93:1996;4589.
8. Koziel M.J., Dudley D., Afdhal N., Choo Q.L., Houghton M., Ralston R., Walker B.D. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 149:1992;3339.
9. Wong D.K.H., Dudley D.D., Afdhal N.H., Dienstag J., Rice C.M., Wang L., Houghton M., Walker B.D., Koziel M.J. Liver-derived CTL in hepatitis C virus infection breadth and specificity of responses in a cohort of persons with chronic infection . J Immunol. 160:1998;1479.
10. Rehermann B., Chang K.M., McHutchinson J.G., Kokka R., Houghton M., Chisari F.V. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest. 98:1996;1432.
11. Koziel M.J., Duddley D., Afdhal N., Grakoui A., Rice C.M., Choo Q.-L., Houghton M., Walker B.D. HLA Class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus Identification of multiple epitopes and characterization of patterns of cytokine release . Clin Invest. 96:1995;2311.
12. Koziel M.J., Dudley D.D., Afdhal N., Choo Q.L., Houghton M., Ralston R., Walker B.D. Hepatitis C virus (HCV) specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 67:1993;7522.
13. Nelson D.R., Marousis C.G., Davis G.L., Rice C.M., Wong J., Houghton M., Lau J.Y.N. The role of hepatitis c virus-specific Cytotoxic T lymphocytes in chronic hepatitis C. J Immunol. 158:1997;1473.
14. Missale G., Bertoni R., Lomonaca V., Valli A., Massari M., Mori C., Rumi M.G., Houghton M., Fiaccadori F., Ferrari C. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest. 98:1996;706.
15. Rehermann B., Chang K.-M., McHutchison J., Kokka M., Houghton C.M., Rice, Chisari F.V. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol. 70:1995;7092.
16. Diepolder H.M., Zachoval R., Hofmann R.M., Wierenga E.A., Santantonio T., Jung M.C., Eichenlaub D., Pape G.R. Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006.
17. Diepolder H.M., Gerlach J.-T., Zachoval R., Hoffmann R.M., Jung M.-C., Wierenga E.A., Scholtz S., Santantonio T., Houghton M., Southwood S., Sette A., Pape G.R. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J Virol. 71:1997;6011.
18. Sette A., Sidney J., del Guercio M.-F., Southwood S., Ruppert J., Dahlberg C., Grey H.M., Kubo R.T. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol. 31:1994;813.
19. Kubo R.T., Sette A., Grey H.M., Appella E., Sakaguchi K., Zhu N.-Z., Arnott D., Sherman H., Shabonowitz J., Michel H., Bodnar W.M., Davis T.A., Hunt D.F. Definition of specific peptide motifs for four major HLA-A alleles. J Immunol. 152:1994;3913.
20. Oseroff C., Sette A., Wentworth P., Fikes J., Kubo R., Chesnut R., Grey H.M., Alexander J. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses. Vaccine. 16:1998;1371.
21. Ruppert J., Sidney J., Celis E., Kubo R.T., Grey H.M., Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A*0201 molecules. Cell. 74:1993;929.
22. Sette A., Vitiello A., Reherman B., Fowler P., Nayersina R., Oseroff C., Yuan L., Ruppert J., Sidney J., del Guercio M.-F., Southwood S., Kubo R.T., Chesnut R.W., Grey H.M., Chisari F.V. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol. 153:1994;5586.
23. Wentworth P.A., Celis E., Crimi C., Stitely S., Hale L., Tsai V., Serra H.M., del Guercio M.-F., Livingston B.D., Alazard D., Fikes J., Kubo R.T., Grey H.M., Chesnut R.W., Sette A. In vitro introduction of primary antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol Immunol. 32:1995;603.
24. Battegay M., Fikes J., Di Bisceglie A.M., Wentworth P.A., Sette A., Celis E., Ching W.-M., Grakoui A., Rice C.M., Kurokohchi K. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2 1 molecules . J Virol. 69:1995;2462.
25. Cerny A., McHutchison J.G., Pasquinelli C., Brown M.E., Brothers M.A., Grobsheid B., Fowler P., Houghton M., Chisari F.V. Cytotoxic T cell lymphocyte response to hepatitis C virus-derived peptides containing the HLA-A2 1 binding motif . J Clin Invest. 95:1995;521.
26. Shirai M., Arichi T., Nishioka M., Nomura T., Keda K.I., Kawaniski K., Engelhard V.H., Feinstone S.M., Berzofsky J.A. CTL responses of HLA-A2.1 transgenic mice specific for hepatitis C viral peptide peptide predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol. 154:1995;2733.
27. Wentworth P.A., Sette A., Celis E., Sidney J., Southwood S., Crimi C., Stitely S., Livingston B., Alazard D., Vitiello A., Grey H.M., Chisari F.V., Chesnut R.W., Fikes J. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome. Int Immunol. 8:1996;651.
28. Wentworth P.A., Vitiello A., Sidney J., Keogh E., Chesnut R.W., Grey H., Sette A. Differences and similarities in the A2 1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice . Eur J Immunol. 26:1996;97.